(Photo : Darko Stojanovic/Pixabay) Laboratory Test Tubes Relyvrio was approved by the US Food and Drug Administration to treat patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. (Photo : Darko Stojanovic/Pixabay)Laboratory Test Tubes Life-threatening ALS According to Billy Dunn, M.D., director of the FDA’s Center ...
View more: FDA Approves Amylyx's Relyvrio as an Option for ALS Treatment